miércoles, 14 de marzo de 2012

Computer software monitoring detects ICD malfunctions sooner / American Heart Association

Computer software monitoring detects ICD malfunctions sooner / American Heart Association


Computer software monitoring detects ICD malfunctions sooner

Study Highlights:
  • A computer software monitoring program provides early warning signs that an implantable cardioverter-defibrillator (ICD) might malfunction.
  • Using the software during the testing and approval process for devices could decrease the risks of patients receiving defective ICDs.
EMBARGOED UNTIL 3 p.m. CT/4 p.m. ET, Tuesday, Mar. 6
DALLAS, March 6, 2012 ― A software monitoring program that tracks implantable cardioverter-defibrillator (ICD) function could detect problems with the devices earlier than current monitoring processes, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
ICDs monitor heart rhythms and deliver electric shocks to restore normal rhythm when life-threatening, irregular heartbeats occur. But the surgically implanted devices can malfunction, particularly in the leads, or wires, that connect them to the heart, causing injury or death.
Device manufacturers track repeated malfunctions and issue recalls if they’re widespread. However, often by the time of the recall, thousands of the devices have been implanted in patients worldwide.
“Current monitoring approaches aimed at reducing harm from malfunctioning medical devices rely largely on voluntary reporting of adverse events by manufacturers, possibly leading to missed warning signs and delayed responses to the problems, such as late recalls,” said Robert G. Hauser, M.D., lead study author and senior consulting cardiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital in Minneapolis, Minn. “We looked at whether using an automated software program to monitor large databases of ICD patients might help us detect potential device-related problems earlier.”
Hauser and colleagues used a commercially available software surveillance program to compare data from about 1,000 patients with recalled leads to about 1,600 patients implanted with ICD leads still on the market. Patients in both databases had their ICDs implanted between 2001 and 2008.
Using the surveillance software, researchers simulated what occurred years earlier. The software detected problems with the recalled leads at least a year before the company had recalled them.
“The software works,” Hauser said. “Looking at ICD patients implanted years ago, we showed that the automated program detects medical device problems faster than current approaches. Pinpointing the malfunction a year earlier in this case could have spared thousands of patients the health risks, costs and inconvenience of receiving a device prone to failure.”
Monitoring newly approved devices could help identify potential problems before the ICDs are introduced on a large scale, he said.
The next step, according to Hauser, is to apply the software to large populations of newly implanted ICD patients, in order to reduce gaps in warning sign detection and action.
Co-authors are Andrew S. Mugglin, Ph.D.; Paul A. Friedman, M.D.; Daniel B. Kramer, M.D.; Linda M. Kallinen, B.S.; Deepa M. McGriff, B.S.; David L. Hayes, M.D. Author disclosures are on the manuscript.
The Minneapolis Heart Institute Foundation and the Abbott Northwestern Hospital Foundation funded the research.
###
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association’s policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding External link.
NR12 – 1037 (CircHF/Hauser)
For Media Inquiries: (214) 706-1173
Cathy Lewis: (214) 706-1324; Cathy.Lewis@heart.org
Bridgette McNeill: (214) 706-1135; Bridgette.McNeill@heart.org
Julie Del Barto (broadcast): (214) 706-1330; Julie.DelBarto@heart.org
For Public Inquiries: (800) AHA-USA1 (242-8721)

2 comentarios:

  1. Intersting and beautiful blog lovely presentation thanks for sharing your views...microsoft excel support We24support tech team are available 24/7 for repairs on computers, printers, laptops, desktops. Our tech team taken to new heights with our technician’s knowledge and support.at 1-866-978-0799 microsoft excel

    ResponderEliminar
  2. The post is absolutely fantastic! Lots of great information and inspiration both of which we all need! Also like to admire the time and effort you put into your blog and detailed information you offer! I will bookmark your blog!

    ResponderEliminar